• Chief Executive Officer

    Steven Lydeamore

    Mr Lydeamore is a FCPA, MBA with 29 years' international pharmaceutical experience. He has senior executive experience spanning Asia Pacific, Europe, Latin America and North America in finance, business development, mergers and acquisitions, sales and marketing, manufacturing, and research and development. Mr Lydeamore worked in various finance roles for F.H. Faulding & Co. Limited in Australia over a ten year period followed by four years in the United States at Mayne Pharma (USA) Limited. For the eleven years' prior to joining Bionomics, Mr Lydeamore worked for Apotex Inc., the largest Canadian-owned pharmaceutical company, most recetly as President, Apobiologix. Mr Lydeamore holds a Bachelor of Business (Applied Economics) (Deakin) and a Master of Business Administration (RMIT). He is a Fellow of CPA Australia, Graduate of Australian Institute of Company Directors and Member of Licensing Executives Society Australia & New Zealand.
  • Head of Business Development & Marketing Communications

    Michael Pryor

    Michael is a Marketing executive with 20 years’ experience in the Australian pharmaceutical industry across marketing, sales and key accounts within the channels of pharmacy, optometry and grocery. He has held various sales and marketing roles with the following multinational companies, Alcon, Allergan, Boehringer Ingelheim, Sanofi and Menarini. Michael has also gained exposure to international markets including New Zealand, Asia Pacific and Europe. In Michael’s most recent role he held the position of Commercial Manager (ANZ) where he led a highly successful team, driving sales, market share and profit growth within the pharmacy channel. During his career thus far, Michael has developed an intimate understanding of the Australian pharmacy channel and has worked across a wide range of therapeutic areas including gut health, eyecare, mental health, cough, sore throat and antiseptics. Michael holds a Bachelor of Business Degree (Marketing) from University of Newcastle and joins Anatara as Head of Business Development and Marketing Communications.
  • Chief Development Officer

    Simon Erskine

    Simon has more than ten years’ experience working within the biotechnology industry, IVD medical devices and molecular diagnostics. He has held positions of increasing responsibility within research and development, clinical development, regulatory and quality and product development. He has successfully translated early-stage research into commercial products for the Australian, European, Canadian and US markets, including commercialisation of novel research for the detection of antibiotic resistance markers.
    Simon has directed global teams and partnerships at scientific, strategic and operational levels, contributing to the rapid growth of Australian biotech start-ups, with roles as Principal Scientist and Director of Product Development. Simon has a history of accomplishments in directing scientific resources and teams on test development, laboratory procedures, quality and resource optimisation. Additionally, Simon has acted as Chief Principal Investigator for human research and clinical studies and participated in clinical research projects within Australia, Europe and the US.